DNTH
Dianthus TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
DNTH vs peer average
45/100
DNTH vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · D 3 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AGIO is the first available peer comparator.
Another rare-disease biotech comparator for cash-backed development-stage valuation and pipeline concentration risk, but only a loose operating peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DNTH
Dianthus Therapeutics
AGIO
Agios
Grade
D
F
Momentum
17
75
Value
41
41
Sentiment
59
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AGIO
DNTH / AGIO
Grade Position
In line
DNTH vs. peer average (D vs. D)
45/100
Momentum
17
AGIOValue
41
DNTHSentiment
59
DNTHRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DNTH
AGIO is the first peer returned for this comparison set.